Cargando…
Clinical Options for the Reduction of Elevated Intraocular Pressure
Elevated IOP in clinical practice is usually seen in glaucoma or ocular hypertension. Glaucoma affects 60 million people worldwide and 8.4 million are bilaterally blind from this chronic disease.1 Options for reducing IOP rely on pharmacological agents, laser treatments and surgery which may be pene...
Autores principales: | Crawley, Laura, Zamir, Sohaib M., Cordeiro, Maria F., Guo, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619493/ https://www.ncbi.nlm.nih.gov/pubmed/23650457 http://dx.doi.org/10.4137/OED.S4909 |
Ejemplares similares
-
Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
por: Aihara, Makoto
Publicado: (2010) -
The Clinical Features of Graves' Orbitopathy with Elevated Intraocular Pressure
por: Fan, Shu-Xian, et al.
Publicado: (2021) -
Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure
por: Quaranta, Luciano, et al.
Publicado: (2015) -
Intraocular Pressure Change and Sustained Intraocular Pressure Elevation After Pars Plana Vitrectomy
por: Cabuk, Kubra Serefoglu, et al.
Publicado: (2021) -
Blood Pressure Modifies Retinal Susceptibility to Intraocular Pressure Elevation
por: He, Zheng, et al.
Publicado: (2012)